azacitidine has been researched along with Autosomal Dominant Cerebellar Ataxia, Type II in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Chen, Y; Chua, B; Feng, Y; Stuart, C; Wang, J; Yan, H; Yin, D; Zhao, J | 1 |
1 other study(ies) available for azacitidine and Autosomal Dominant Cerebellar Ataxia, Type II
Article | Year |
---|---|
β-arrestin2/miR-155/GSK3β regulates transition of 5'-azacytizine-induced Sca-1-positive cells to cardiomyocytes.
Topics: Animals; Antimetabolites, Antineoplastic; Arrestins; Azacitidine; beta-Arrestins; Cell Differentiation; Cell Proliferation; Cells, Cultured; Fluorescent Antibody Technique; Glycogen Synthase Kinase 3; Glycogen Synthase Kinase 3 beta; Male; Mice; Mice, Inbred C57BL; Mice, Knockout; MicroRNAs; Myocardial Reperfusion Injury; Myocytes, Cardiac; Real-Time Polymerase Chain Reaction; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Spinocerebellar Ataxias | 2014 |